Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.60 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590438 | 1.00 | TAAR1 (0.60) | TAAR1IDO1GPR52TDP1TSHR | |
| Phosphine SCHEMBL8416873 | 0.98 | TAAR1 (0.58) | TAAR1IDO1GPR52TDP1TSHR | |
| SCHEMBL4119364 | 0.88 | TAAR1 (0.48) | TAAR1IDO1GPR52TDP1TSHR | |
| SCHEMBL534245 | 0.86 | TAAR1 (0.56) | TAAR1IDO1GPR52TSHRCYP2A13 | |
| SCHEMBL30769022 | 0.86 | TAAR1 (0.56) | TAAR1IDO1GPR52TSHRCYP2A13 | |
| SCHEMBL3028718 | 0.84 | TAAR1 (0.54) | TAAR1IDO1GPR52TSHRALDH1A1 | |
| SCHEMBL29351396 | 0.84 | TAAR1 (0.71) | TAAR1IDO1GPR52TSHRCYP2A13 | |
| SCHEMBL6738136 | 0.84 | TAAR1 (0.71) | TAAR1IDO1GPR52TSHRCYP2A13 | |
| SCHEMBL9026542 | 0.82 | TAAR1 (0.52) | TAAR1IDO1GPR52TSHRALDH1A1 | |
| SCHEMBL22288310 | 0.81 | TAAR1 (0.40) | TAAR1IDO1GPR52TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 823 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772063-B | Preparation process and method of chloro (bromo) styrene | 中国科学院大连化学物理研究所 | 2025-04-29 | — | — | CN | claimed |
| CN-116023231-A | Method for preparing chloro (bromo) styrene by dehydration of chloro (bromo) phenethyl alcohol | 中国科学院大连化学物理研究所 | 2023-04-28 | — | — | CN | claimed |
| CN-115772063-A | Preparation process and method of chloro (bromo) styrene | 中国科学院大连化学物理研究所 | 2023-03-10 | — | — | CN | claimed |
| CN-115557836-A | Preparation method of carboxylic acid | 云南大学 | 2023-01-03 | — | — | CN | claimed |
| CN-113333018-A | Preparation method and application of supported catalyst for preparing halogenated styrene | 中触媒新材料股份有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-111233908-A | Benzoxaborol-1-ol compound and preparation method and application thereof | 南京农业大学 | 2020-06-05 | — | — | CN | claimed |
| CN-107857702-A | A kind of preparation method of bilastine intermediate | 重庆华邦制药有限公司 | 2018-03-30 | — | — | CN | claimed |
| WO-2013102935-A2 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-07-11 | — | — | WO | claimed |
| CN-101565679-B | Rhodotorula cell and method for producing optical active alcohols by asymmetric conversion | UNIV CHINA PHARMA | 2013-05-08 | — | — | CN | claimed |
| CN-101565679-A | Rhodotorula cell and method for producing optical active alcohols by asymmetric conversion | UNIV CHINA PHARMA (CN) | 2009-10-28 | — | — | CN | claimed |
| EP-1542672-A4 | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | CHENG J L (US) | 2006-06-07 | — | — | EP | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-1542672-A2 | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | Cheng, J. L. (US) | 2005-06-22 | — | — | EP | claimed |
| WO-2004014290-A2 | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | CHENG J L (US) | 2004-02-19 | — | — | WO | claimed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-3980722-A | Production of bromostyrene, dibromostyrene and alkyl bromides | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1976-09-14 | — | — | US | disclosed |
| US-3966831-A | Production of bromostyrenes | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1976-06-29 | — | — | US | disclosed |
| US-3957787-A | CENTRAL NERVOUS SYSTEM STIMULANTS, MUSCLE RELAXANTS | E. R. SQUIBB & SONS, INC. (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630566-B2 | KRas G12D inhibitors | KRAS, NRAS, HRAS | TAAR1 4774/4885IDO1 4512/4885GPR52 1643/4885 |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | HBZ, HBB, HBG2 | TAAR1 2113/4885IDO1 2695/4885GPR52 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.